LAURALIE JOHNSON: Open Payments
NPI 1033638168 · MONROVIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $192 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $120 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Noven Therapeutics, LLC | 2 | $40 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $34 |
Products named: INGREZZA, CAPLYTA, REXULTI, Xelstrym.
Industry payments across CA — which companies pay providers there.
